Abstract
Patients with hepatocellular carcinoma (HCC) have both disease- and treatment-related increased symptom burden and decreased health-related quality of life (HRQoL). The aim of this study was to obtain a detailed understanding of the patient experience of HCC-related signs/symptoms and impacts on daily functioning and HRQoL through qualitative interviews, to guide fit-for-purpose patient-centred outcome measurement in medical product development.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
